Abstract:Objective To explore the validity and security of enhanced recovery after surgery (ERAS) in kidney transplantation recipients during perioperative managemant.Methods The clinical data of 474 kidney transplantation recipients who received kidney transplantation in Kidney Disease Center,the First Affiliated Hospital,School of Medicine,Zhejiang University during July 2016 to August 2017 were retrospectively analysed,among which 315 recipients who got traditional perioperative managemant during July 2016 to April 2017 were divided into traditional group,and 159 recipients who got ERAS during perioperative managemant were diveded into ERAS group.The main content of ERAS included bowel preparation removal,preoperative carbohydrate loading,early-stage feeding,early mobilization,multimodal approach to opioid-sparing pain control and so on.Indexes like mean post operation hospitalization duration,serum creatinine,gastrointestinal reaction,delayed graft dysfunction (DGF),acute reaction during 90 days after surgery,incidence rate of new-onset diabetes mellitus after transplantation and unscheduled readmission rate during 90 days after surgery were compared between the 2 groups.Measurement data like age,weight and time of dialysis preoperative between the 2 groups were compared by Student's t-test,and enumeration data like incidence rate of DGF and acute reaction during 90 days after surgery between the 2 groups were compared by chi-square test.Results No statistical difference was found in gender,age,height,weight,time of dialysis preoperative,type of donor kidney and HLA mismatch number between the 2 groups (P all ＞ 0.05).The post operation hospitalization duration of living donor renal transplantation recipients and cadaveric donor renal transplantation recipients in ERAS group were (7.7 ± 2.0) d and (12.8 ± 8.3) d,respectively,which were shorter than traditional group [(9.0 ±3.8) d and (16.7 ± 12.6) d],and the difference was statistically significant (t =-2.594 and-2.692,P all ＜ 0.05).No statistical difference was found in serum creatinine of 7,30 and 90 days after transplantation between the 2 groups (P all ＞ 0.05).The incidence rate of diarrhea of ERAS group and traditional group were 5.7％ (9/159) and 20.7％ (65/315),respectively,which had statistical difference (x2 =18.092,P ＜ 0.05).No statistical difference was found in DGF,acute reaction during 90 days after transplantation,new-onset diabetes mellitus after transplantation,incidence rate of other complications and unscheduled readmission rate during 90 days after surgery between the 2 groups (P all ＞ 0.05).Conclusions ERAS protocol can decreased post operation hospitalization duration and incidence rate of diarrhea without influence on other complications,which was safe and effective.

Nursing care of peri perioperative application of plasma diafiltration in liver transplantation complicated with acute renal failure

Nursing Experience of 61 Patients with Hepatic Cirrhosis Treated by Transfusion of Ultrafiltrated and Concentrated Self-Ascites

Assessment of the Combined Effect of Plasma Exchange and Plasma Perfusion on Patients with Severe Hepatitis Awaiting Orthotopic Liver Transplantation

Effects of Plasma Exchange Combined with Continuous Renal Replacement Therapy on Acute Fatty Liver of Pregnancy.

Analysis of Clinical Effect of Continuous Plasma Diafiltration for the Therapy of Liver Failure

Plasma Exchange-Centered Artificial Liver Support System in Hepatitis B Virus-Related Acute-on-chronic Liver Failure: a Nationwide Prospective Multicenter Study in China.

A Clinical Study on the Treatment of Severe Hepatitis by a Combined Artificial Liver.

Extra-corporeal non-liver transplant therapies for acute liver failure: Focus on plasma exchange and continuous renal replacement therapy

Treatment of rejection and highly sensitized in kidney transplantation with double filtration plasmapheresis

Efficacy of Coupled Low-Volume Plasma Exchange with Plasma Filtration Adsorption in Treating Pigs with Acute Liver Failure: A Randomised Study.

Application of Continuous Veno-Venous Hemodiafiltration to Severely Acute Renal Failure after Cardiac Surgery

[Clinical Research of Plasma Exchange with Continuous Veno-Venous Hemofiltration in Treating Mid- and Late-Stage Chronic Severe Viral Hepatitis B Patients].

The Application of Enhanced Recovery after Surgery in Kidney Transplantation Recipients During Perioperative Managemant

Clinical effects of double filtration plasmapheresis for sensitized recipients of cadaver kidney transplantation

Effects of Hemoperfusion Adsorption And/or Plasma Exchange in Treatment of Severe Viral Hepatitis: A Comparative Study

Changes of serum cytokine levels in patients with acute on chronic liver failure treated by plasma exchange.

Application of Continuous Renal Replacement Therapy in the peripoerative patients with Acute Kidney Injury ;after lung transplantation

Anesthetic support in synchronous liver and kidney transplantation

Three Artificial Liver Models of Treatment of Acute-on-Chronic Liver Failure

Perioperative management in liver transplantation for acute liver failure

Peritoneal dialysis effectively removes toxic substances and improves liver functions of liver failure patients